Supplemental material
Journal of Liposome Research
Volume 34, 2024 - Issue 3
Research Articles
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells
Yu Gaoa Faculty of Medical and Health Sciences, School of Pharmacy, The University of Auckland, Auckland, New Zealand
https://orcid.org/0000-0003-2615-617XView further author information
https://orcid.org/0000-0003-2615-617XView further author information, Andrew N. Shellingb Faculty of Medical and Health Sciences, School of Medicine, The University of Auckland, Auckland, New Zealandhttps://orcid.org/0000-0002-5300-1934View further author information
https://orcid.org/0000-0002-5300-1934View further author information, Emma Nolanc Faculty of Medical and Health Sciences, Auckland Cancer Society Research Centre, The University of Auckland, Auckland, New Zealandhttps://orcid.org/0000-0002-8705-847XView further author information
https://orcid.org/0000-0002-8705-847XView further author information, David Porterd Auckland Regional Cancer and Blood Service, Auckland City Hospital, Auckland, New Zealandhttps://orcid.org/0000-0002-3115-8244View further author information
https://orcid.org/0000-0002-3115-8244View further author information, Euphemia Leungc Faculty of Medical and Health Sciences, Auckland Cancer Society Research Centre, The University of Auckland, Auckland, New Zealandhttps://orcid.org/0000-0002-6932-3188View further author information
https://orcid.org/0000-0002-6932-3188View further author information & Zimei Wua Faculty of Medical and Health Sciences, School of Pharmacy, The University of Auckland, Auckland, New ZealandCorrespondence[email protected]
https://orcid.org/0000-0001-9777-0674View further author information
https://orcid.org/0000-0001-9777-0674View further author information